Mustang Bio’s $40 Million Public Offering

Ambrogio Visconti North America, North America Legal Chronicle

Alston & Bird advised Mustang Bio Inc. Mustang Bio Inc.,a clinical-stage biopharmaceutical company, has closed a public offering of common stock aimed at raising approximately $40…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Ambrogio Visconti

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here